Literature DB >> 14758

Stereochemical specificity in the antipsychotic effects of flupenthixol in man [proceedings].

T J Crow, E C Johnstone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 14758      PMCID: PMC1667994     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  4 in total

1.  Stereospecificity of interaction of neuroleptic drugs with neurotransmitters and correlation with clinical potency.

Authors:  S J Enna; J P Bennett; D R Burt; I Creese; S H Snyder
Journal:  Nature       Date:  1976-09-23       Impact factor: 49.962

2.  EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

Authors:  A CARLSSON; M LINDQVIST
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

3.  Experimental neurological syndromes and the new drug therapies in psychiatry.

Authors:  P DENIKER
Journal:  Compr Psychiatry       Date:  1960-04       Impact factor: 3.735

4.  Effect of drugs used in psychoses on cerebral dopamine metabolism.

Authors:  R O'Keeffe; D F Sharman; M Vogt
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

  4 in total
  3 in total

1.  The effect of dopamine and noradrenaline blockade on amphetamine-induced behaviour in the marmoset.

Authors:  P R Scraggs; R M Ridley
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

2.  Neuroleptic drugs block both the hyperactivity and the increase in caudate nucleus cyclic AMP concentration produced by the administration of tranylcypromine and L-dopa to rats.

Authors:  D J Heal; A R Green; M R Bloomfield; D G Grahame-Smith
Journal:  Psychopharmacology (Berl)       Date:  1978-04-28       Impact factor: 4.530

Review 3.  Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.

Authors:  Jataveda Mahapatra; Seema N Quraishi; Anthony David; Stephanie Sampson; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2014-06-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.